Comparative pharmacokinetics of submucosal vs. intravenous flumazenil (Romazicon®) in an animal model

Pediatric Dentistry

Volumn 22, Issue 6, 2000, Pages 489-493

  Oliver, Faith M ^a   Sweatman, Trevor W ^a   Unkel, John H ^a   Kahn, Michael A ^a   Randolph, Mildred M ^a   Arheart, Kristopher L ^a   Mandrell, Timothy D ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR AFFECTING AGENT; COLORING AGENT; DIAGNOSTIC AGENT; FLUMAZENIL;

ANIMAL; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BIOPSY; BLOOD; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DOG; DRUG EFFECT; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUTH MUCOSA; OBSERVER VARIATION; ORAL DRUG ADMINISTRATION; PATHOLOGY; SAFETY;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; BIOPSY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLORING AGENTS; CONFIDENCE INTERVALS; DOGS; FLUMAZENIL; FOLLOW-UP STUDIES; GABA MODULATORS; INJECTIONS, INTRAVENOUS; MALE; MODELS, ANIMAL; MOUTH MUCOSA; OBSERVER VARIATION; SAFETY;

EID: 0034321961     PISSN: 01641263     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Report of an expert working party (Poswillo Report): General anaesthesia, sedation and resuscitation in dentistry. Standing Dental Advisory Committee, London: HMSO 1990.
2. McCloy RF, Pearson RC: Which agent and how to deliver it. A review of benzodiazepine sedation and its reversal in endoscopy. Scand J Gastroent. 25 (Suppl 179):7-11, 1990.
3. McCloy RF: Reversal of conscious sedation by flumazenil: current status and future prospects. Acta Anaesthesiol Scand. 39 (Suppl 108):35-42, 1995.
4. Buhrer M, Maitre PO, Crevoisier C, et al: Electroencephalographic effects of benzodiazepines: II. Pharmacodynamic modeling of the electroencephalographic effects of midazolam and diazepam. Clin Pharmacol Ther. 48:555-67, 1990.
5. Bonetti EP, Pieri L, Cumin R, Schaffner M, Pieri M, et al: Benzodiazepine antagonist Ro 15-1788: neurological and behavioral effects. Psychopharmacology 78:8, 1982.
6. Bichard AL, Little HJ: Differential effects of the benzodiazepine antagonist Ro 15-1788 on the "general anaesthetic" actions of the benzodiazepines. Brit J Anaesthesia 55:912P, 1983.
7. Pole P, Bonetti EP, Schaffner R, Haefely W: A three-state model of the benzodiazepine receptor explains the interactions between the benzodiazepine antagonist Ro 15-1788, benzodiazepine tranquilizers, beta-carbolines, and phenobarbitone. Naunyn Schmiedebergs Arch Pharmacol. 321:260-64, 1982.
8. Zambotti F, Zonta N, Tammiso R, Ferrario P, Hafner B, Mantegazza P: Reversal of the effect of centrally-administered diazepam on morphine antinociception by specific (Ro 15-1788 and Ro 15-3505) and non-specific (bicuculline and caffeine) benzodiazepine antagonists. Naunyn Schmiedebergs Arch Pharmacol. 333:43-46, 1986.
9. Jones RD, Chan K, Roulson CJ, et al: Pharmacokinetics of flumazenil and midazolam. Brit J Anaesthesia 70:286-92, 1993.
10. Roche package insert for flumazenil (Romazicon®). Rev 10/94.
11. Persson A, Ehrin E, Eriksson L, Farde L, Hedstrom CG, Litton JE, Mindus P, Sedvall G: Imaging of [11C]-labelled Ro 15-1788 binding to benzodiazepine receptors in the human brain by positron emission tomography. J Psychiatr Res. 19:609-22, 1985.
12. Savic I, Thorell JO: localized cerebellar reductions in benzodiazepine receptor density in human partial epilepsy. Arch Neurol. 53:656-62, 1996.
13. Klotz U, Kanto J: Pharmacokinetics and clinical use of flumazenil (Ro 15-1788). Clin Pharmacokinet 14(1):1-12, 1988.
14. Carbajal R, Simon N, Blanc P, Paupe A, Lenclen R, Oliver-Martin M: Rectal flumazenil to reverse midazolam sedation in children. Anesth Analg 82:895, 1996.
15. Palmer RB, Mautz DS, Cox K, Kharasch ED: Endotracheal flumazenil: a new route of administration for benzodiazepine antagonism. Am J Emerg Med 16:170-2, 1998.
16. Schlappi B, Bonetti EP, Strobel R: Toxicological investigations with the benzodiazepine antagonist flumazenil. Drug Res 38(I)Nr 2:247-50, 1988.
17. Klotz U: Drug interactions and clinical pharmacokinetics of flumazenil. Eur J Anaesthesiol Suppl 2:103-108, 1988.
18. Mandema JW, Gubbens-Stibbe JM, Danhof M: Stability and pharmacokinetics of flumazenil in the rat. Psychopharmacology 103:384-87, 1991.
19. Brogden RN, Goa KL: Flumazenil: a preliminary review of its benzodiazepines antagonistic properties, intrinsic activity and therapeutic use. Drugs 35(4):448-67, 1988.
20. Whitwam JG, Amrein R: Pharmacology of flumazenil. Acta Anaesthsia Scand 39(Suppl 108):3-14, 1995.
21. Roncari G, Ziegler WH, Guentert TW: Pharmacokinetics of the new benzodiazepine antagonist Ro 15-1788 in man following intravenous or oral administration. Brit J Clin Pharmacol 22:421-28, 1986.
22. Reves JG, Glass PSA, Lubarsky DA: Nonbarbiturate Intravenous Anesthetics In: Anesthesia, Fifth Edition (Miller RD, ed), Churchill Livingstone Inc, 1999.
23. Ashton H: Benzodiazepine withdrawal: an unfinished story. Br Med J 288:1135-40, 1984.
24. Cumin R, Bonetti EP, Scherschlicht R, Haefley WE: Use of the specific benzodiazepine antagonist Ro15-1788 in studies of physiological dependnece on benzodiazepines. Experientia 38:833-34, 1984.
25. Lheureux P, Askenasi R: Specific treatment of benzodiazepine overdose. Human Toxicol 7:165, 1988.
26. Schulze-Bonhage A, Elger CE: Induction of partial epileptic seizures by flumazenil. Epilepsia 41:186-92, 2000.
27. Klotz U, Zeigler G, Reimann IW: Pharmacokinetics of the selective benzodiazepine antagonist Ro 15-1788 in man. Eur J Clin Pharmacol. 27(1):115-17, 1984.
28. Savid I, Widen L, Stone-Elander S: Feasibility of reversing benzodiazepine tolerance with flumazenil. Lancet 337:133-37, 1991.
29. Schmitt M, Nazif MM, Mckee KC, et al: Pharmacokinetics and local responses to submucosal meperidine compared with other routes of administration. Ped Dent 16(3):190-92, 1994.
30. Zhu W: Making bootstrap statistical inferences: a tutorial. Res Q Exer Sport 68(1):44-55, 1997.
31. Wasserman S, Bockenholt U: Bootstrapping: applications to psychology. Psychophysiology 26(2):208-21, 1989.
32. Zhi J, Massarella JW, Melia AT, Teller SB, et al: The pharmacokinetic-pharmacodynamic (Digit Symbol Substitution Test) relationship of flumazenil in a midazolam steady-state model in healthy volunteers. Clin Pharm Ther 56:530-36, 1994.